Mutations in the BRCA1 and BRCA2 genes account for the majority of families with six or more cases of early-onset breast and/or ovarian cancer; however, many families with a high incidence of breast cancer have no detectable mutations in BRCA1 or BRCA2 [46], suggesting the existence of additional breast cancer susceptibility genes. This evidence concerns the gene BRCA2 and ovarian cancer.